SynthesisBioMed research international2021

The Predictive Efficacy of Tumor Mutation Burden (TMB) on Nonsmall Cell Lung Cancer Treated by Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

Zhang Nan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.